Abstract
Many transplant patients are given the drug cyclosporine to suppress their immune systems and prevent rejection. But cyclosporine also increases the risk of cancer, always thought to be a side effect of the depressed Immune system. A new study shows that cyclosporine directly affects tumour growth and may be the culprit.
Original language | English (US) |
---|---|
Pages (from-to) | 471-472 |
Number of pages | 2 |
Journal | Nature |
Volume | 397 |
Issue number | 6719 |
DOIs | |
State | Published - Feb 11 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- General